(AKBA) Akebia Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Akebia Therapeutics | (AKBA) share price targets
Complete technical analysis of Akebia Therapeutics (AKBA) by charts plus indicators, forecast predictions and share price targets for Akebia Therapeutics (AKBA)
Akebia Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-02-26 View latest technical analysis
10 day averaged volume of Akebia Therapeutics is 2201540
Date | Daily Closing Price | Open | High | Low | Volume |
26 Mon Feb 2024 | 1.51 | 1.38 | 1.54 | 1.37 | 1.334 times |
23 Fri Feb 2024 | 1.35 | 1.40 | 1.40 | 1.32 | 1.4 times |
22 Thu Feb 2024 | 1.39 | 1.42 | 1.47 | 1.38 | 1.051 times |
21 Wed Feb 2024 | 1.42 | 1.46 | 1.48 | 1.41 | 0.848 times |
20 Tue Feb 2024 | 1.44 | 1.46 | 1.51 | 1.42 | 1.131 times |
16 Fri Feb 2024 | 1.45 | 1.45 | 1.48 | 1.43 | 0.879 times |
15 Thu Feb 2024 | 1.47 | 1.53 | 1.54 | 1.40 | 1.616 times |
14 Wed Feb 2024 | 1.53 | 1.55 | 1.58 | 1.52 | 0.649 times |
13 Tue Feb 2024 | 1.52 | 1.62 | 1.63 | 1.50 | 0.96 times |
12 Mon Feb 2024 | 1.62 | 1.62 | 1.67 | 1.61 | 0.862 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 1.5 as stoploss in an intra day buy trade for a target of 1.57. However, stock will show a bearish move below 1.5.
Share price targets for Akebia Therapeutics (AKBA)
Target Type | Value |
Downside Target | 0.78 |
Downside Target | 0.84 |
Downside Target | 1.02 |
Downside Target | 1.16 |
Downside Target | 1.21 |
Downside Target | 1.31 |
Downside Target | 1.37 |
Downside Target | 1.40 |
Downside Target | 1.51 |
Upside Target | 1.58 |
Upside Target | 1.67 |
Upside Target | 1.73 |
Upside Target | 1.74 |
Upside Target | 1.82 |
Intraday share price targets for Akebia Therapeutics (AKBA)
Target Type | Value |
Downside Intraday Target | 1.41 |
Downside Intraday Target | 1.3 |
Upside Intraday Target | 1.58 |
Upside Intraday Target | 1.64 |
Downside Intraday Target | 1.47 |
Weekly technical analysis of Akebia Therapeutics (AKBA)
Date | Weekly Closing Price | Open | High | Low | Volume |
26 Mon Feb 2024 | 1.51 | 1.38 | 1.54 | 1.37 | 0.301 times |
23 Fri Feb 2024 | 1.35 | 1.46 | 1.51 | 1.32 | 0.892 times |
16 Fri Feb 2024 | 1.45 | 1.62 | 1.67 | 1.40 | 1.753 times |
09 Fri Feb 2024 | 1.64 | 1.65 | 1.73 | 1.59 | 0.518 times |
02 Fri Feb 2024 | 1.65 | 1.63 | 1.82 | 1.58 | 1.466 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Akebia Therapeutics (AKBA)
Date | Monthly Closing Price | Open | High | Low | Volume |
26 Mon Feb 2024 | 1.51 | 1.70 | 1.74 | 1.32 | 0.684 times |
31 Wed Jan 2024 | 1.68 | 1.22 | 1.82 | 1.21 | 1.625 times |
29 Fri Dec 2023 | 1.24 | 1.06 | 1.31 | 1.02 | 1.105 times |
30 Thu Nov 2023 | 1.06 | 0.88 | 1.16 | 0.84 | 0.837 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Akebia Therapeutics (AKBA)
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Akebia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Akebia Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Akebia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Akebia Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akebia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.46 and Akebia Therapeutics (AKBA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Akebia Therapeutics (AKBA) stock. Volume based technical analysis of Akebia Therapeutics (AKBA) stock is negative.
Akebia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Akebia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Akebia Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Akebia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Akebia Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Akebia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.46 and Akebia Therapeutics (AKBA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Akebia Therapeutics (AKBA) stock. Volume based technical analysis of Akebia Therapeutics (AKBA) stock is negative.
Akebia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.